+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Medical Professional Liability Insurance - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 120 Pages
  • July 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6260242
The medical professional liability insurance market size is expected to increase from USD 17.69 billion in 2025 to USD 18.82 billion in 2026 and reach USD 26.24 billion by 2031, growing at a CAGR of 6.87% over 2026-2031. This report is Segmented by Coverage Type (Occurrence-Based, Claims-Made), by Claim Category (Diagnosis-Related, Medication-Related Errors, and More), by Insured Entity Type (Individual Practitioners, and More), by Distribution Channel (Retail Agents & Brokers, and More), by Geography (North America, South America, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Medical Professional Liability Insurance Market Trends and Insights

Rising Severity of Misdiagnosis and Treatment Error Claims

The medical professional liability insurance market continues to be driven by diagnostic failures and treatment errors, as these claims now yield larger payouts, even as overall claim frequency does not rise at the same pace. In 2024, the top 50 United States malpractice awards averaged USD 56 million, 14% above 2023, according to WTW, which showed that high-value awards have moved into a more sustained pattern. Milliman also reported that indemnity payments for its composite of 170 United States specialty carriers exceeded USD 2.9 billion through the first 3 quarters of 2025, up 17%, while claim frequency remained broadly flat. That split between stable frequency and rising severity means carriers must price for larger awards, more complex expert testimony, and longer claim development periods, rather than relying on older frequency-based assumptions. The medical professional liability insurance market is therefore responding with firmer pricing, closer claims review, and more pressure on claims-made reserve assumptions. Carriers that do not keep pace with this shift in 2026 and 2027 risk weaker reserve adequacy and lower underwriting margins in later reporting periods.

Expansion of High-Risk Outpatient and Ambulatory Care Settings

The medical professional liability insurance market is gaining new exposure from outpatient and ambulatory settings, as more procedures that once took place in hospitals are now moving to centers with different staffing and monitoring models. CMS finalized the 2026 Ambulatory Surgery Center payment rule in November 2025 and added 573 procedures to the covered procedures list, including higher-acuity surgeries that expand the liability profile of outpatient providers. These settings often operate with leaner staffing than hospitals, which changes the operational risks around anesthesia oversight, informed consent, documentation, and post-operative observation. Hospital-sponsored insurance programs also do not always absorb the full outpatient exposure, so standalone professional liability coverage remains necessary for many facility owners and operators. The medical professional liability insurance market benefits from this widening exposure base because ambulatory surgery centers, day-surgery sites, and similar facilities add new premium demand without fully matching the loss history of acute hospital towers. A similar expansion is also occurring across private healthcare systems in the Asia-Pacific, where new outpatient capacity is increasing before broad public indemnity protections have fully developed.

Long-Tail Loss Uncertainty And Reserve Volatility

The medical professional liability insurance market remains constrained by very long claim tails, as some injuries, especially those involving minors, can remain open for many years before full settlement and reserve closure. In 2025, claims-made carriers recognized USD 259 million in adverse development, with large contributions from Curi Holdings, Liberty Mutual Holding, and Farmers Insurance Group as court backlogs eased and more claims moved forward. AM Best also noted that favorable reserve development narrowed to USD 155 million in 2025, far below the larger capital cushion the line had enjoyed in earlier years. When reserve redundancy shrinks, carriers have less flexibility to compete on price because they can no longer rely on future reserve releases to offset weak underwriting periods. The medical professional liability insurance market, therefore, sees slower new capacity formation and more careful rate discipline when claim development becomes harder to predict. This reserve pressure matters most in long-tail books, where a pricing error made today can continue affecting reported results for many years.

Other drivers and restraints analyzed in the detailed report include:

  • Litigation Funding and Nuclear Verdict Escalation
  • Telemedicine And AI-Enabled Care Creating New Liability Triggers
  • Reinsurance Tightness for Catastrophic Medical Towers

Segment Analysis

Claims-made coverage held 77.56% of the coverage-type segment in 2025, and this part of the medical professional liability insurance market is forecast to grow at a 7.1% CAGR from 2026 to 2031. Its lead reflects the way most commercial carriers and hospital systems prefer a structure that links coverage to the reporting period and makes reserve management more responsive to current loss conditions. In the medical professional liability insurance market, that flexibility matters because carriers can respond more quickly to severity pressure rather than carrying perpetual exposure to older underwriting years. Claims-made forms also align more closely with the capital and reporting disciplines expected under state insurance supervision and risk-based capital frameworks. This is why claims-made business continues to anchor portfolio economics, even when reserve shocks persist within that structure.

The reserve record shows both the strength and the burden of this model. Claims-made carriers recognized USD 259 million in adverse development in 2025, while occurrence business posted USD 15.7 million in favorable development during the same period, which showed where severity pressure was most visible in current reporting. Occurrence coverage still has a place for hospitals and physician groups that want continuing protection without later tail purchases when a clinician exits a practice or changes employment. Even so, the pricing challenge posed by very long liability tails limits faster adoption of occurrence forms while severity is still rising. The medical professional liability insurance industry, therefore, continues to lean toward claims-made products because they provide a cleaner path for rate correction, reserve recognition, and capital planning.

Diagnosis-related claims accounted for 32.67% of the segment in 2025, and this portion of the medical professional liability insurance market size is projected to expand at a 7.6% CAGR from 2026 to 2031. Misdiagnosis, delayed diagnosis, and failure to diagnose remain central because they combine high frequency with the potential for severe patient outcomes and large awards. The medical professional liability insurance market keeps this category at the front because diagnostic failures often involve complex questions of judgment, documentation, escalation, and timing rather than a single visible procedural error. Those features can make both causation and defense strategy more difficult when a case reaches litigation. The category also benefits from the broader shift toward digital and virtual care, where incomplete examination and fragmented information can complicate the diagnostic record.

Telehealth adds another layer to this pattern because virtual interactions can leave more ambiguity around physical examination, symptom interpretation, and patient follow-up. The American Medical Association's telehealth adoption data supports the view that remote care is now mainstream, which means the underlying exposure base for diagnostic disputes is no longer narrow. Treatment-related and procedure-related claims remain the second-largest block of exposure, as outpatient and ambulatory procedure volumes continue to rise across several specialties. Medication-related claims are also receiving more attention in markets that are digitizing prescribing and recordkeeping, which improves traceability but can also more clearly highlight system-based mistakes. Obstetrics continues to stand out as the highest-severity subcategory, and the American Medical Association reported that ob-gyns face a career-lawsuit probability near 60%, with premiums for the specialty reaching USD 243,988 in Florida in 2025.

Complete Report Scope:

  • By Coverage Type
    • Occurrence-Based Coverage
    • Claims-Made Coverage
  • By Claim Category
    • Diagnosis-Related (Misdiagnosis, Delayed Diagnosis, Failure to Diagnose)
    • Treatment / Procedure-Related (Surgical Errors, Anesthesia Errors, Wrong-Site Procedures)
    • Medication-Related Errors
    • Obstetrics / Childbirth-Related Injuries
    • Other Allegations (minimized residual category)
  • By Insured Entity Type
    • Individual Practitioners
      • Physicians & Surgeons
      • Dentists
      • Nurses & Allied Health Professionals
      • Other Individual Practitioners
    • Institutional / Facility Providers
      • Hospitals & Health Systems
      • Clinics, Ambulatory Surgical Centers & Outpatient Facilities
      • Nursing Homes / Long-Term Care Facilities
      • Diagnostic & Ancillary Service Providers
      • Other Institutional Providers
  • By Distribution Channel
    • Retail Agents & Brokers
    • Wholesale / Surplus Lines Brokers
    • Captives, Risk Retention Groups (RRGs) & Self-Insurance Programs
    • Direct / Institutional Placements (including hospital-sponsored programs for employed physicians)
    • Other Channels (e.g., MGAs, affinity programs)
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Europe
      • United Kingdom
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Indonesia
      • Thailand
      • Malaysia
      • Singapore
      • Vietnam
      • Rest of Asia-Pacific
    • Middle East and Africa
      • Saudi Arabia
      • United Arab Emirates
      • Turkey
      • South Africa
      • Egypt
      • Rest of Middle East and Africa

Geography Analysis

North America held 62.34% of the medical professional liability insurance market share in 2025, and the region remains the primary demand center, combining a large private healthcare base with a highly developed tort environment. The United States drove most of that scale and recorded the seventh consecutive annual rise in physician premiums in 2025, while the American Medical Association reported that 36 states saw at least 1 premium increase. The medical professional liability insurance market in North America is also shaped by major differences in tort law, damage caps, and legal climate from one state to another, which makes local underwriting discipline more important than national averages. Canada follows a different model because public indemnity arrangements soften some of the private-market volatility seen in the United States. Mexico remains a smaller and less mature private liability market, but growth is linked to the expansion of private hospitals and specialist care.

Europe presents a more mandate-driven structure in the medical professional liability insurance market, as liability coverage is often anchored in professional regulation, public indemnity design, or a mix of both. Germany requires liability insurance for licensed physicians, which supports recurring premium demand even when practice settings differ across individual and group structures. The United Kingdom follows a distinct pattern in which National Health Service indemnity schemes absorb much of the hospital risk, while private demand is concentrated among independent consultants and general practice partners. France and other continental markets still face long-tail complexity because civil liability cases can take extended periods to resolve and reserve. Europe is therefore more stable in terms of mandatory demand, yet still complex in legal structure, technical margins, and cross-country claims behavior.

Asia-Pacific is the fastest-growing regional market for medical professional liability insurance and is forecast to expand at a 9.2% CAGR from 2026 to 2031. Growth is tied to greater patient rights awareness, the spread of private healthcare, and the gradual formalization of professional liability across large and mid-sized healthcare systems. In Japan, the market continues to benefit from structured physician liability arrangements, and Sompo Japan launched a medical accident data analysis service for hospital clients in June 2025 to support loss prevention through closed-claim analytics. South America, the Middle East, and Africa still account for smaller shares of the medical professional liability insurance market, but they are adding incremental volume as private hospital capacity expands in countries such as Brazil, Saudi Arabia, and the United Arab Emirates. Mandatory practitioner coverage in parts of the Gulf and the rise of organized private providers across emerging markets support long-term expansion, even though insurance penetration remains below the healthcare revenue base in many of these systems.



List of Companies Covered in this Report:

  • Berkshire Hathaway Inc.
  • The Doctors Company
  • Chubb Limited
  • AIG
  • CNA Financial Corporation
  • ProAssurance Corporation
  • Coverys
  • MagMutual Insurance Company
  • Medical Protective
  • Zurich Insurance Group Ltd.
  • Allianz SE
  • AXA SA
  • Beazley PLC
  • Hiscox Ltd.
  • Tokio Marine Holdings, Inc.
  • Munich Reinsurance Company
  • Assicurazioni Generali S.p.A.
  • Aon plc
  • Marsh McLennan
  • Arthur J. Gallagher & Co.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Severity of Misdiagnosis and Treatment Error Claims
4.2.2 Expansion of High-Risk Outpatient and Ambulatory Care Settings
4.2.3 Mandatory Coverage Expansion in Regulated Healthcare Systems
4.2.4 Digital Underwriting and Claims Automation Adoption
4.2.5 Litigation Funding and Nuclear Verdict Escalation
4.2.6 Telemedicine and AI-Enabled Care Creating New Liability Triggers
4.3 Market Restraints
4.3.1 Long-Tail Loss Uncertainty and Reserve Volatility
4.3.2 Reinsurance Tightness for Catastrophic Medical Towers
4.3.3 Fragmented Legal Regimes and Cross-Jurisdiction Pricing Complexity
4.3.4 Under-Insurance and Low Penetration in Emerging Healthcare Markets
4.4 Value Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter’s Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 MARKET SIZE AND GROWTH FORECASTS
5.1 By Coverage Type
5.1.1 Occurrence-Based Coverage
5.1.2 Claims-Made Coverage
5.2 By Claim Category
5.2.1 Diagnosis-Related (Misdiagnosis, Delayed Diagnosis, Failure to Diagnose)
5.2.2 Treatment / Procedure-Related (Surgical Errors, Anesthesia Errors, Wrong-Site Procedures)
5.2.3 Medication-Related Errors
5.2.4 Obstetrics / Childbirth-Related Injuries
5.2.5 Other Allegations (minimized residual category)
5.3 By Insured Entity Type
5.3.1 Individual Practitioners
5.3.1.1 Physicians & Surgeons
5.3.1.2 Dentists
5.3.1.3 Nurses & Allied Health Professionals
5.3.1.4 Other Individual Practitioners
5.3.2 Institutional / Facility Providers
5.3.2.1 Hospitals & Health Systems
5.3.2.2 Clinics, Ambulatory Surgical Centers & Outpatient Facilities
5.3.2.3 Nursing Homes / Long-Term Care Facilities
5.3.2.4 Diagnostic & Ancillary Service Providers
5.3.2.5 Other Institutional Providers
5.4 By Distribution Channel
5.4.1 Retail Agents & Brokers
5.4.2 Wholesale / Surplus Lines Brokers
5.4.3 Captives, Risk Retention Groups (RRGs) & Self-Insurance Programs
5.4.4 Direct / Institutional Placements (including hospital-sponsored programs for employed physicians)
5.4.5 Other Channels (e.g., MGAs, affinity programs)
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 South America
5.5.2.1 Brazil
5.5.2.2 Argentina
5.5.2.3 Rest of South America
5.5.3 Europe
5.5.3.1 United Kingdom
5.5.3.2 Germany
5.5.3.3 France
5.5.3.4 Italy
5.5.3.5 Spain
5.5.3.6 Rest of Europe
5.5.4 Asia-Pacific
5.5.4.1 China
5.5.4.2 Japan
5.5.4.3 India
5.5.4.4 South Korea
5.5.4.5 Australia
5.5.4.6 Indonesia
5.5.4.7 Thailand
5.5.4.8 Malaysia
5.5.4.9 Singapore
5.5.4.10 Vietnam
5.5.4.11 Rest of Asia-Pacific
5.5.5 Middle East and Africa
5.5.5.1 Saudi Arabia
5.5.5.2 United Arab Emirates
5.5.5.3 Turkey
5.5.5.4 South Africa
5.5.5.5 Egypt
5.5.5.6 Rest of Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
6.4.1 Berkshire Hathaway Inc.
6.4.2 The Doctors Company
6.4.3 Chubb Limited
6.4.4 AIG
6.4.5 CNA Financial Corporation
6.4.6 ProAssurance Corporation
6.4.7 Coverys
6.4.8 MagMutual Insurance Company
6.4.9 Medical Protective
6.4.10 Zurich Insurance Group Ltd.
6.4.11 Allianz SE
6.4.12 AXA SA
6.4.13 Beazley PLC
6.4.14 Hiscox Ltd.
6.4.15 Tokio Marine Holdings, Inc.
6.4.16 Munich Reinsurance Company
6.4.17 Assicurazioni Generali S.p.A.
6.4.18 Aon plc
6.4.19 Marsh McLennan
6.4.20 Arthur J. Gallagher & Co.
6.5 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
6.5.1 White-Space and Unmet-Need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Berkshire Hathaway Inc.
  • The Doctors Company
  • Chubb Limited
  • AIG
  • CNA Financial Corporation
  • ProAssurance Corporation
  • Coverys
  • MagMutual Insurance Company
  • Medical Protective
  • Zurich Insurance Group Ltd.
  • Allianz SE
  • AXA SA
  • Beazley PLC
  • Hiscox Ltd.
  • Tokio Marine Holdings, Inc.
  • Munich Reinsurance Company
  • Assicurazioni Generali S.p.A.
  • Aon plc
  • Marsh McLennan
  • Arthur J. Gallagher & Co.